Intervention

SPC5004

ClinicalTrials.gov intervention label

Clinical trials1

Recruiting0

Common conditions4

Lead sponsors shown1

Clinical trials

1 shown

Evaluate the Efficacy and Safety of SPC1001 Low in Patients With Essential HypertensionNCT07064525 · 2024-12-05

ENROLLING_BY_INVITATION

Common conditions

Diabete Mellitus1 Hypertension (HTN)1 NYHA Class III Heart Failure1 NYHA Class IV Heart Failure1

Leading sponsors

Shin Poong Pharmaceutical Co. Ltd.1

Trial status mix

ENROLLING_BY_INVITATION1

Phase mix

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.